Search

TUESDAY, Feb. 2, 2021 (HealthDay News) — Young Black heart recipients have an increased risk for mortality in the first year after transplant, according to a study published online Feb. 2 in Circulation: Heart Failure. Hasina Maredia, M.D., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues studied 22,997 adult heart transplant...

Findings show it is effective and feasible to combine cardiac nurse-led cognitive-behavioral therapy with cardiac rehab. Cognitive-behavioral therapy (CBT) provided by cardiac nurses in conjunction with cardiac rehabilitation (CR) cuts anxiety and depression symptoms in heart patients, according to a study published online Jan. 18 in the European Heart Journal. Annette Holdgaard, from Bispebjerg and Frederiksberg...

MONDAY, Oct. 19, 2020 (HealthDay News) — Most patients with congenital heart disease (CHD) are not at risk for severe COVID-19 infection, according to a study published online Oct. 14 in the Journal of the American Heart Association. Matthew J. Lewis, M.D., from the Columbia University Irving Medical Center in New York City, and colleagues...

FRIDAY, March 5, 2021 (HealthDay News) — Among heart failure patients, hospital readmission is frequent and often occurs in the early postdischarge period, according to a study published online Feb. 17 in ESC Heart Failure. Maria Wideqvist, M.D., from the University of Gothenburg in Sweden, and colleagues examined factors associated with readmissions among 448 consecutive...

Source: www.BloodJournal.org Hypertension with ibrutinib more common than previously reported; this study is first to show association between cancer drug-related hypertension and other heart problems (WASHINGTON, October 3, 2019) — Over half of people prescribed the targeted blood cancer-fighting drug ibrutinib developed new or worsened high blood pressure within six months of starting the medication, according...

For patients with type 2 diabetes (T2D) receiving first-line sodium-glucose cotransporter-2 inhibitors (SGLT-2i), the risk for stroke, myocardial infarction (MI), and all-cause mortality is similar to those receiving metformin, and the risk for hospitalization for heart failure (HHF) is lower, according to a study published in the Annals of Internal Medicine. HoJin Shin, Ph.D., from...

Heart issues are common among people with sickle cell disease. Among them are enlargement of the heart and an impaired ability to relax the heart, a condition called diastolic dysfunction that can lead to heart disease, heart failure, and death. Long-term treatment with hydroxyurea, however, seems to improve and even reverse some of these abnormalities,...

Treating sickle cell anemia with the drug hydroxyurea may also reverse related heart abnormalities, a new study suggests. Heart issues are common among people with sickle cell disease. Among them are enlargement of the heart and an impaired ability to relax heart muscles, a condition called diastolic dysfunction that can lead to heart disease and...

Diabetes is a risk factor of both hypertension and coronary artery disease due to increased systemic pressures and increased atherosclerosis, increasing the risk of cardiomyopathy and congestive heart failure. There is a high prevalence of diabetes mellitus among heart failure patients with one study showing a 40% of hospitalized heart failure patients having comorbid diabetes...